Tag: therapeutic radioisotope lutetium-177
Clinical trial of Akiram’s cancer drug candidate AKIR001
Akiram Therapeutics, a Swedish biotech company specializing in targeted radiotherapy, announced that the first patient has been enrolled in the Phase 1 clinical trial...